Who Attends

Seize this opportunity to engage and network with 350+ experts
pioneering the gene therapy field.

The therapeutic potential of gene therapies is clear, but in order for this potential to be realized, lessons and key insights from the companies who are directly involved in cutting edge development work must be shared and disseminated. Gene Therapy for Rare Disorders’ specific focus of means it is an unparalleled opportunity to engage in meaningful discussion with 350+ experts at the forefront of this field.

100+ organizations joined us in 2018 including:

New interactive networking opportunities:

Interactive sessions built into the main agenda provide extensive opportunities for cross-functional collaboration. Benchmark your progress and critically evaluate your development and  commercialization strategies.

Leave with clear and actionable insights that will prepare you for a year of unprecedented progress in the field.

"The quality of attendees are what make a great conference - The people attending it were absolutely first-rate so pat on the back of Hanson Wade for ensuring that."
Adith Venkiteshwaran, Sanofi Genzyme

"Networking format was second to none - wish all conferences added such value."
Patrick DePalma, Emergent BioSolutions

Audience breakdown:

* Statistics based on the attendee list for Gene Therapy for Rare Disorders 2018